HER2 and TOP2A in high-risk early breast cancer patients treated with adjuvant epirubicin-based dose-dense sequential chemotherapy

BACKGROUND: HER2 and TOP2A parameters (gene status, mRNA and protein expression) have individually been associated with the outcome of patients treated with anthracyclines. The aim of this study was to comprehensively evaluate the prognostic/predictive significance of the above parameters in early,...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:
Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς: Fountzilas, George, Valavanis, Christos, Kotoula, Vassiliki, Eleftheraki, Anastasia G, Kalogeras, Konstantine T, Tzaida, Olympia, Batistatou, Anna, Kronenwett, Ralf, Wirtz, Ralph M, Bobos, Mattheos, Timotheadou, Eleni, Soupos, Nikolaos, Pentheroudakis, George, Gogas, Helen, Vlachodimitropoulos, Dimitrios, Polychronidou, Genovefa, Aravantinos, Gerasimos, Koutras, Angelos, Christodoulou, Christos, Pectasides, Dimitrios, Arapantoni, Petroula
Μορφή: Artigo
Γλώσσα:Inglês
Έκδοση: BioMed Central 2012
Θέματα:
Research
Διαθέσιμο Online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3275536/
https://ncbi.nlm.nih.gov/pubmed/22240029
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1479-5876-10-10
Ετικέτες: Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Παρόμοια τεκμήρια